To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

PHASE4RecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Heart DiseasesHeart Valve Diseases
Interventions
DRUG

Esketamine hydrochloride injection

The low dose esketamine hydrochloride group was given 0.2mg/kg at induction of anesthesia, the high dose esketamine hydrochloride group was given 0.4mg/kg at induction of anesthesia, and the blank control group was not given Esketamine hydrochloride injection at induction of anesthesia.

Trial Locations (1)

563000

RECRUITING

Affiliated Hospital of Zunyi Medical University, Zunyi

All Listed Sponsors
lead

Zhang XIao Mei

OTHER